U.S. Market for Orthopedic Biomaterials 2010
In 2009, the orthopedic biomaterials market was valued at almost $3.5 billion. This market is expected to grow at a CAGR of 8.9% by 2016. The total orthopedic biomaterials market has experienced growth, despite the economic downturn, which began in 2008. The market started to spike in 2009 and peaked in 2010 largely driven by rapid growth in the stem cell, hyaluronic acid and synthetic bone graft substitute market segments.
This comprehensive report critically examines the following market segments:
- Bone graft substitutes
- Cartilage repair
- Growth factors
- Hyaluronic acid
- Machined allografts
- Resorbable fixation
- Stem cells
- Tendon grafts
- Platelet rich plasma
- Bone marrow concentration systems
Within the U.S. orthopedic biomaterials market, companies such as Arthrex, DePuy, Genzyme, Medtronic, Synthes and Smith & Nephew lead the market, among many others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2016, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios.
Buy Now : Market Research
Related Reports
- U.S. Market for Dental Bone Graft Substitutes and Other Biomaterials 2010
- U.S. Market for Orthopedic Trauma Devices 2010
- U.S. Market for Orthopedic Large Joint Reconstructive Devices 2010
- U.S. Market for Orthopedic Soft Tissue and Sports Medicine 2010
- Asia Pacific Markets for Orthopedic Biomaterials 2009 (4 Countries)
- Europe Orthopedic Biomaterials Market: Product Penetration to Drive Growth
- European Markets for Orthopedic Biomaterials 2009 (15 Countries)
- U.S. Market for Orthopedic Bioabsorbable Bone Pins and Screws 2009
- U.S. Market for Small Bone & Joint Orthopedic Devices 2009
- U.S. Market for Orthopedic Reconstructive Devices 2008
